Navigation Links
Breast-Specific Gamma Imaging (BSGI) Found to Be Highly Sensitive for Early Stage Breast Cancer

Researchers Determine BSGI a Useful Tool in Detection, as Sensitive as MRI

for Invasive Cancers and Perhaps More So for DCIS

NEWPORT NEWS, Va., May 29 /PRNewswire/ -- According to an article in the June issue of Radiology, researchers at The George Washington University Medical Center in Washington, D.C. have shown that Breast-Specific Gamma Imaging (BSGI) is highly sensitive in detecting the presence of cancer. The researchers determined that BSGI was a useful detection tool and that it was as sensitive as MRI for most cancers and perhaps more sensitive for ductal carcinoma in-situ, an early stage of breast cancer.

BSGI, molecular imaging of the breast utilizing a high-resolution, small-field-of-view gamma camera, is an increasingly utilized adjunct imaging modality for the diagnosis of breast cancer. Initial studies with this imaging technique report sensitivities similar to MRI with a higher specificity -- which is the ability of a test to show when disease is not present.

In the retrospective study, 146 women underwent BSGI and breast biopsy. Study images were assigned scores, and scores were classified as positive or negative and compared with biopsy results. BSGI helped detect cancer in 96.4% of the noted malignant lesions; the positive predictive value was 68.8%, specificity of 59.5% and the negative predictive value for nonmalignant lesions was 94.3%. The smallest invasive cancer and DCIS detected were both 1 mm, and BSGI helped detect occult cancer not visualized at mammography or ultrasonography in six patients.

Mammography remains the imaging modality of choice for breast cancer screening. The overall sensitivity of mammography has been reported to be 78 - 85 percent; however, the sensitivity of mammography decreases to 42 - 68 percent in women with dense breasts. In addition, the false-positive rate of screening mammography is 15 - 30 percent, leading to many benign findings at biopsy. Limitations in the sensitivity and specificity of screening mammography led to the investigation of adjunct breast imaging modalities; specifically BSGI, which provides physiological data not obtained with the anatomic imaging techniques of mammography and ultrasound.

"Our study supports the use of BSGI because MR imaging would be used in clinical practice with equal sensitivity and higher specificity. An advantage of BSGI is the greater comfort of the patient, with the study being performed with the patient sitting as opposed to being placed in an MR imager. Additionally, BSGI results in four to eight images as compared with several hundred images in a breast MR examination, leading to a associated decrease in interpretation time. In our practice, BSGI has been integrated in the daily evaluation of patients, as appropriate," said Dr. Rachel Brem of The George Washington University Medical Center.

Breast-Specific Gamma Imaging as an Adjunct Imaging Modality for the Diagnosis of Breast Cancer

Radiology, Volume 247, No 3, June 2008 (Rachel F. Brem, MD, Angelique C. Floerke, MD, PharmD, Jocelyn A. Rapelyea, MD, Christine Teal, MD, Tricia Kelly, MD, Vivek Mathur, MD).

About Dilon Technologies

Dilon Technologies is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Northwestern Memorial Hospital, Chicago; and The Rose, Houston. For more information on Dilon Technologies please visit

SOURCE Dilon Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Breast Cancer Imaging Study Indicates Breast-Specific Gamma Imaging (BSGI) Is a Strong Adjunct Imaging Modality to Mammography and Ultrasound
2. Breast-Specific Gamma Imaging (BSGI) Changes Patient Care Management
3. Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms
4. Gamma Labs to Boost Testosterone At World Series of Poker In Las Vegas
5. Gamma Secretase Modulators Show Promise in Alzheimers Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics
6. SNM hosts 55th Annual Meeting of Nuclear Medicine and Molecular Imaging Research
7. MR imaging accurately determines prostate cancer treatment failure
8. University of Virginia Health System invests in IMRISneuro, the next generation of surgical imaging technology
9. High-Tech Imaging No Better for Diagnosing Head/Neck Cancers
10. Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center
11. Improving anxiety treatment through the help of brain imaging: A potential future treatment strategy
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: